9 Moreover, it increases the risk of http://www.selleckchem.com/products/ABT-888.html developing resistance. Chemoprophylaxis can contribute to the widespread emergence and dissemination of antimicrobial resistance,

as observed in Madagascar in 2000, where resistance to tetracycline developed following extensive use of the drug.10 Tetracycline-resistant V. cholerae O1 isolates are being increasingly reported worldwide.11 The value of selective chemoprophylaxis during a cholera epidemic depends on local circumstances and may be useful for members of a household, under the same roof and eating the same food as a cholera patient.12 The role of chemoprophylaxis in limiting cholera epidemics is difficult to ascertain. Large-scale prophylaxis should be selective and limited to close contacts, in accordance with WHO recommendations, with strict application and check details monitoring of both integrated prevention procedures and antibiotic susceptibility. Nevertheless, antibiotics were extensively used, both for

curative and prophylactic purposes, to prevent an explosive spread of the 2004 cholera epidemic in Douala.13 Despite the risks of massive and prolonged use of antibiotics, strictly prescribed and controlled, no resistance developed in the identified strain. Chemoprophylaxis must follow rigorous protocols and be continuously monitored.13 A recent systematic review14 assesses the effects of chemoprophylaxis in preventing cholera among exposed contacts. Their findings suggest that chemoprophylaxis has a protective effect among household contacts of people with cholera, but the results are based on studies with a high likelihood of bias. Hence, there is a need for reliable research evaluating the effects of chemoprophylaxis, enabling a balance to be found between harm and benefit. In conclusion, this study underlines the interest of investigating food-borne outbreaks

even in settings with poor laboratory resources, and the potential dual efficacy of doxycycline chemoprophylaxis against malaria. We thank Angela Verdier for revision of the manuscript. The authors state they have no conflicts of interest to declare. “
“The aim of this study was to evaluate the level of poliomyelitis immunization in Anidulafungin (LY303366) refugees residing in the Asylum Seeker Center in Bari. The study was carried out during 2008 and involved 573 refugees. An antibody titer ≥1:8 was found in 99.6% for poliovirus 1, in 99.8% for poliovirus 2, and in 99.5% for poliovirus 3. In 1988, the World Health Assembly resolved to eradicate poliomyelitis worldwide by the year 2000.1 Thanks to the consistent implementation of vaccination strategies, the number of endemic countries decreased from 1252 in 1988 to 4 (Nigeria, India, Pakistan, and Afghanistan) in 2008 with a >99% reduction of paralytic polio cases.